Trial · NCT02100839
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants Who Incurred at Least One Treatment Emergent Event | AEM-28 | 33 | participants | ||
| Number of Participants Who Incurred at Least One Treatment Emergent Event | Normal Saline | 10 | participants | ||
| Number of Participants Who Incurred Mild Treatment Emergent Adverse Events | AEM-28 | 33 | Number of Participants | ||
| Number of Participants Who Incurred Mild Treatment Emergent Adverse Events | Normal Saline | 10 | Number of Participants | ||
| Number of Participants Who Incurred Moderate Treatment Emergent Events | AEM-28 | 7 | Number of Participants | ||
| Number of Participants Who Incurred Moderate Treatment Emergent Events | Normal Saline | 0 | Number of Participants | ||
| Very Low Density Lipoprotein Cholesterol (VLDL-C) Percent Change | AEM-28 | Part A: 3.54 mg/kg | -72.1 | Standard Deviation 15.1 | Max % Change Versus Baseline |
| Very Low Density Lipoprotein Cholesterol (VLDL-C) Percent Change | Normal Saline | Part A: 3.54 mg/kg | -0.33 | Standard Deviation 0.17 | Max % Change Versus Baseline |
| Very Low Density Lipoprotein Cholesterol (VLDL-C) Percent Change | AEM-28 | Part B: 3.54 mg/kg | -79.2 | Standard Deviation 13.5 | Max % Change Versus Baseline |
| Very Low Density Lipoprotein Cholesterol (VLDL-C) Percent Change | Normal Saline | Part B: 3.54 mg/kg | -0.58 | Standard Deviation 0.31 | Max % Change Versus Baseline |
| Very Low Density Lipoprotein Cholesterol (VLDL-C) Percent Change | AEM-28 | Part A: 2.0 mg/kg | -76.3 | Standard Deviation 7.25 | Max % Change Versus Baseline |
| Very Low Density Lipoprotein Cholesterol (VLDL-C) Percent Change | Normal Saline | Part A: 2.0 mg/kg | -0.35 | Standard Deviation 0.13 | Max % Change Versus Baseline |
| Very Low Density Lipoprotein Cholesterol (VLDL-C) Percent Change | AEM-28 | Part B: 2.0 mg/kg | -73.3 | Standard Deviation 6.36 | Max % Change Versus Baseline |
| Very Low Density Lipoprotein Cholesterol (VLDL-C) Percent Change | Normal Saline | Part B: 2.0 mg/kg | -0.52 | Standard Deviation 0.15 | Max % Change Versus Baseline |
| Very Low Density Lipoprotein Cholesterol (VLDL-C) Percent Change | AEM-28 | Part A: 1.0 mg/kg | -47.9 | Standard Deviation 19.7 | Max % Change Versus Baseline |
| Very Low Density Lipoprotein Cholesterol (VLDL-C) Percent Change | Normal Saline | Part A: 1.0 mg/kg | -0.23 | Standard Deviation 0.15 | Max % Change Versus Baseline |
| Very Low Density Lipoprotein Cholesterol (VLDL-C) Percent Change | AEM-28 | Part B: 1.0 mg/kg | -51.8 | Standard Deviation 24.7 | Max % Change Versus Baseline |
| Very Low Density Lipoprotein Cholesterol (VLDL-C) Percent Change | Normal Saline | Part B: 1.0 mg/kg | -0.38 | Standard Deviation 0.19 | Max % Change Versus Baseline |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02100839/results